SCHEMBL23068559

SCHEMBL23068559

Clc1nc2c(c(NC34CC(C3)C4)n1)SCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31670511 0.78 — —
SCHEMBL373964 0.74 — —
SCHEMBL30686987 0.72 PDE4A (0.43) —
SCHEMBL31622413 0.72 — —
SCHEMBL29138592 0.72 PDE4A (0.43) —
SCHEMBL14734141 0.72 LATS1 (0.33) —
SCHEMBL187242 0.72 — —
SCHEMBL30639334 0.72 LATS1 (0.33) —
SCHEMBL19624252 0.71 — —
SCHEMBL23084550 0.71 NPC1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3724194-B1 SUBSTITUTED AZETIDINE DIHYDROTHIENOPYRIMIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS UNION THERAPEUTICS AS (DK) 2023-12-27 — — EP disclosed
US-11292799-B2 Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors UNION therapeutics A/S (DK) 2022-04-05 — — US disclosed
US-20210070769-A1 SUBSTITUTED AZETIDINE DIHYDROTHIENOPYRIMIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS UNION therapeutics A/S (DK) 2021-03-11 — — US disclosed
US-20210070769-A1 SUBSTITUTED AZETIDINE DIHYDROTHIENOPYRIMIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS UNION therapeutics A/S (DK) 2021-03-11 — — US disclosed
Send feedback